Skip to main content

Advertisement

SpringerLink
Log in

Ist eine medikamentöse Thromboseprophylaxe im Rahmen der Implantation von zentralvenösen Kathetern erforderlich?

Is prophylactic thrombosis medication necessary for implantation of central venous catheters?

  • Fragen aus der Praxis
  • Published:
Gefässchirurgie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Abdelkefi A, Ben Othman T, Kammoun L et al (2004) Prevention of central venous line-related thrombosis by continous infusion of low-does unfractioned heparin in patients with haemato-oncological disease – a randomized controlled trial. Thromb Haemost 92:654–661

    PubMed  CAS  Google Scholar 

  2. Akl EA, Kamath G, Yosuico V et al (2008) Thromboprophylaxis for patients with cancer and central venous catheters. A systematic review and a meta-analysis. Cancer 112:2483–2892

    Article  PubMed  CAS  Google Scholar 

  3. Bern MM, Lokich JJ, Wallach SR et al (1990) Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial. Ann Intern Med 112:423–428

    PubMed  CAS  Google Scholar 

  4. Bonnizzoli M, Batacchi S, Cianchi G et al (2010) Peripherally inserted central venous catheters and central venous catheters related thrombosis in post-critical patients. Intensive Care Med Sept 21 (Epub ahead of print)

  5. De Cicco M, Matovic M, Balestreri L et al (2009) Early and short-term acenocumarine or dalteparin for the prevention of central vein catheter-related thrombosis in cancer patients: a randomized controlled study based on serial venographies. Ann Oncol 20:1936–1942

    Article  Google Scholar 

  6. Debourdeau P, Kassab Chahmi D, Le Gal G et al (2009) 2008 SOR guidelines for the prevention and treatment of thrombosis associated with central venous catheters in patients with cancer: report from the working group. Ann Oncol 20:1459–1471

    Article  PubMed  CAS  Google Scholar 

  7. Evans RS, Sharp JH, Linford LH et al (2010) Risk of symptomatic DVT associated with peripherally inserted central catheters. Chest 138:803–810

    Article  PubMed  Google Scholar 

  8. Gaitini D, Beck-Razi N, Haim N et al (2006) Prevalence of upper extremity deep venous thrombosis diagnosed by color Doppler duplex sonography in cancer patients with central venous catheters. J Ultrasound Med 25:1297–1303

    PubMed  Google Scholar 

  9. Geerts WH, Pineo GF, Heit JA et al (2004) Prevention of venous thrombembolism: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126:338S–400S

    Article  PubMed  CAS  Google Scholar 

  10. Heaton DC, Han DY, Inder A (2002) Minidose (1 mg) warfarin as prophylaxis for central vein catheter thrombosis. Intern Med J 32:84–88

    Article  PubMed  CAS  Google Scholar 

  11. Karthaus M, Kretzschmar A, Kroning H et al (2006) Dalteparin for the prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial. Ann Oncol 17:289–296

    Article  PubMed  CAS  Google Scholar 

  12. Kuter D (2004) Thrombotic complications of central venous catheters in cancer patients. Oncologist 9:207–216

    Article  PubMed  Google Scholar 

  13. Lee A, Levine MN, Butler G et al (2006) Incidence, risk factors and outcomes of catheter-related thrombosis in adult patients with cancer. J Clin Oncol 24:1404–1408

    Article  PubMed  Google Scholar 

  14. Linenberger ML (2006) Catheter related thrombosis: risks, diagnosis and management. J Natl Compr Canc Netw 4:889–901

    PubMed  Google Scholar 

  15. Monreal M, alastrue A, Rull M et al (1996) Upper extremity deep venous thrombosis in cancer patients with venous access devices – prophylaxis with low molecular weight heparin (Fragmin). Thromb Haemost 75:251–253

    PubMed  CAS  Google Scholar 

  16. Verso M, Agnelli G (2003) Venous thrombembolism associated with long-term use of central venous catheter in cancer patients. J Clin Oncol 21:3665–3675

    Article  PubMed  Google Scholar 

  17. Verso M, Agnelli G, Bertoglio S et al (2005) Enoxaparin for the prevention of venous thrombembolism associated with central vein catheter: a double-blind, placebo-controlled, randomized study in cancer patients. J Clin Oncol 23:4057–4062

    Article  PubMed  CAS  Google Scholar 

  18. Young AM, begum G, Billingham LJ et al (2005) WARP – a multi-centre prospective randomized trial (RCT) of thrombosis prophylaxis with warfarin in cancer patients with central venous catheters (CVCs). Proc Am Soc Clin Oncol 23:(16 Suppl) Abstract LBA8004

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

  1. Sektion Gefäßchirurgie, Krankenhaus Merheim, Kliniken der Stadt Köln, Ostmerheimer Str. 200, 51109, Köln, Deutschland

    M. Aleksic

  2. Abteilung für Gefäßchirurgie, Elisabeth Krankenhaus Recklinghausen, Recklinghausen, Deutschland

    M. Pillny

Authors
  1. M. Aleksic
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Pillny
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Aleksic.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Aleksic, M., Pillny, M. Ist eine medikamentöse Thromboseprophylaxe im Rahmen der Implantation von zentralvenösen Kathetern erforderlich?. Gefässchirurgie 16, 273–274 (2011). https://doi.org/10.1007/s00772-011-0907-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00772-011-0907-1

Search

Navigation